HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F. Krakow, Marie Bleakley, Melinda A. Biernacki et al.|Blood|2024Cited by 29
Expanding the Role of SH2B3: T Cell Large Granular Lymphocytosis (LGL) and Common Variable Immune Deficiency in the Setting of Biallelic SH2B3 MutationsTiffany Hangse, Eric J. Allenspach, Shalini Pullarkat et al.|Blood|2024Cited by 2